Beyond Air Inc (XAIR)

Sep 10, 2026, 3:55 PM EDT - 9 days ago

Beyond Air Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

Sep 2, 2026, 8:00 AM EDT - 18 days ago

Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference

2026-09-01T12:45:40.000Z - 19 days ago

Beyond Air initiated with a Buy at Lake Street on durable recurring revenue

2026-09-01T12:26:10.000Z - 19 days ago

Beyond Air initiated with a Buy at Lake Street

2026-08-31T12:10:56.000Z - 20 days ago

Beyond Air gets Breakthrough Device Designation for LungFit GO

Aug 31, 2026, 8:00 AM EDT - 20 days ago

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

2026-08-25T11:10:14.000Z - 26 days ago

Beyond Air to sell NeuroNOS stake to Univo Pharmaceutical

Aug 25, 2026, 7:00 AM EDT - 26 days ago

Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments

Aug 25, 2026, 7:00 AM EDT - 26 days ago

Beyond Air Slides: Corporate presentation

2026-08-17T20:55:07.000Z - 4 weeks ago

Beyond Air files to sell 5.42M shares of common stock for holders

Aug 17, 2026, 8:00 AM EDT - 4 weeks ago

Beyond Air Registration statement: Registration filing

Aug 13, 2026, 8:00 AM EDT - 5 weeks ago

Beyond Air Earnings Call Transcript: Q1 2027

Aug 13, 2026, 8:00 AM EDT - 5 weeks ago

Beyond Air Earnings release: Q1 2027

Aug 13, 2026, 8:00 AM EDT - 5 weeks ago

Beyond Air Quarterly report: Q1 2027

Aug 13, 2026, 7:00 AM EDT - 5 weeks ago

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Aug 4, 2026, 8:00 AM EDT - 6 weeks ago

Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

Jul 30, 2026, 7:00 AM EDT - 7 weeks ago

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

2026-07-10T23:50:45.000Z - 2 months ago

Beyond Air trading halted, news pending

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Beyond Air Earnings Call Transcript: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Beyond Air Earnings release: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Beyond Air Annual report: Q4 2026

2026-06-26T11:20:47.000Z - 2 months ago

Beyond Air narrows FY26 revenue view to $8M from $8M-$10M, consensus $8.08M

2026-06-26T11:20:37.000Z - 2 months ago

Beyond Air sees FY27 revenue $16M-$18M, consensus $12.7M

2026-06-26T11:15:15.000Z - 2 months ago

Beyond Air reports Q4 EPS (77c) vs. ($1.79) last year

Jun 26, 2026, 7:00 AM EDT - 2 months ago

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Jun 22, 2026, 4:01 PM EDT - 2 months ago

Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast

Jun 10, 2026, 8:00 AM EDT - 3 months ago

Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting

2026-06-01T13:58:00.000Z - 3 months ago

Beyond Air receives Nasdaq hearing panel decision granting continued listing

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

May 5, 2026, 8:00 AM EDT - 4 months ago

Beyond Air Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Beyond Air Proxy statement: Proxy filing

2026-04-20T12:58:40.000Z - 5 months ago

Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial

Apr 20, 2026, 8:00 AM EDT - 5 months ago

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 5 months ago

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

2026-03-26T20:10:58.000Z - 5 months ago

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

2026-03-17T20:45:51.000Z - 6 months ago

Beyond Air subsidiary reports signs of clinical activity from UNO trial

Mar 17, 2026, 4:35 PM EDT - 6 months ago

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 12, 2026, 2:30 PM EDT - 6 months ago

Beyond Air Transcript: Life Sciences Virtual Investor Forum

2026-03-10T11:35:43.000Z - 6 months ago

Beyond Air announces termination of NeuroNOS agreement with XTL

XTLB

2026-02-20T13:08:00.000Z - 7 months ago

Beyond Air announces publication of review article on effects of iNO

Feb 20, 2026, 8:00 AM EST - 7 months ago

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

2026-02-19T21:31:02.000Z - 7 months ago

Beyond Air price target lowered to $2 from $6 at JonesResearch

Feb 13, 2026, 8:00 AM EST - 7 months ago

Beyond Air Earnings Call Transcript: Q3 2026

Feb 13, 2026, 8:00 AM EST - 7 months ago

Beyond Air Earnings release: Q3 2026

Feb 13, 2026, 8:00 AM EST - 7 months ago

Beyond Air Quarterly report: Q3 2026

2026-02-13T12:36:07.000Z - 7 months ago

Beyond Air reports Q3 EPS (85c) vs ($2.96) last year

Feb 13, 2026, 7:30 AM EST - 7 months ago

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Feb 13, 2026, 6:00 AM EST - 7 months ago

Beyond Air Slides: Corporate presentation

Jan 30, 2026, 7:00 AM EST - 7 months ago

Beyond Air Registration statement: Registration Filing

Jan 27, 2026, 4:05 PM EST - 7 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Jan 15, 2026, 1:30 PM EST - 8 months ago

Beyond Air Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Jan 13, 2026, 7:30 AM EST - 8 months ago

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Dec 19, 2025, 7:00 AM EST - 9 months ago

Beyond Air Proxy statement: Proxy Filing

Dec 11, 2025, 7:00 AM EST - 9 months ago

Beyond Air Registration statement: Registration Filing

Nov 26, 2025, 4:30 PM EST - 9 months ago

Beyond Air® Announces Transition of Chief Financial Officer

Nov 21, 2025, 7:00 AM EST - 10 months ago

Beyond Air Registration statement: Registration Filing

Nov 10, 2025, 4:30 PM EST - 10 months ago

Beyond Air Earnings Call Transcript: Q2 2026

Nov 10, 2025, 4:30 PM EST - 10 months ago

Beyond Air Quarterly report: Q2 2026

Nov 10, 2025, 4:30 PM EST - 10 months ago

Beyond Air Earnings release: Q2 2026

Nov 10, 2025, 4:05 PM EST - 10 months ago

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:00 AM EST - 10 months ago

Beyond Air Slides: Corporate presentation

Sep 30, 2025, 8:00 AM EDT - 11 months ago

Beyond Air Registration statement: Registration Filing

Sep 25, 2025, 8:00 AM EDT - 12 months ago

Beyond Air Registration statement: Registration Filing

Sep 22, 2025, 8:00 AM EDT - 12 months ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 8, 2025, 3:55 PM EDT - 1 year ago

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Quarterly report: Q1 2026

Jul 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 22, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Annual report: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q4 2025

Jun 17, 2025, 4:01 PM EDT - 1 year ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 16, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

May 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

May 5, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 21, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 15, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 9, 2025, 4:05 PM EDT - 1 year ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings release: Q3 2025

Feb 10, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 9:29 AM EST - 1 year ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 31, 2025, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Jan 27, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 24, 2025, 9:15 AM EST - 1 year ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Jan 13, 2025, 10:30 AM EST - 1 year ago

Beyond Air Transcript: Lytham Partners 2025 Investor Healthcare Summit

Dec 9, 2024, 11:00 AM EST - 1 year ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 4, 2024, 4:30 PM EST - 1 year ago

Beyond Air Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 3, 2024, 4:05 PM EST - 1 year ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 2, 2024, 7:30 AM EST - 1 year ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Nov 26, 2024, 7:30 AM EST - 1 year ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 21, 2024, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Nov 14, 2024, 4:05 PM EST - 1 year ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q2 2025

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q2 2025

Nov 11, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 29, 2024, 4:22 PM EDT - 1 year ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Registration statement: Registration Filing

Oct 18, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 7, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 2, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Sep 27, 2024, 7:34 AM EDT - 1 year ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:32 AM EDT - 1 year ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules